LEVETIRACETAM, 100mg/ml, 5ml, vial
STD
DINJLEVE5V-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
07/11/2024, 20:37:29
Former
Code(s):
DINJLEVE5A-
5.1 - Antiseizure medicines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
N03AX14
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
LEVETIRACETAM
- Not in the WHO list of Essential Medicines 2023
Therapeutic Action
Indications
Convulsive status epilepticus in infants, children and pregnant women.
Contact your OC advisor for the treatment protocol.
Instructions for use
Dilute the concentrate solution vial in at least 100 ml of 0.9% NaCl.
Must be given as slow IV infusion.
Levetiracetam can be used as an alternative first-line treatment when phenobarbital is not available.
Injectable valproate sodium can be used as an alternative for epilepsy, in adults only.
Due to the international shortage of injectable phenobarbital and phenytoin, levetiracetam is an alternative for the management of status epilepticus in infants, children, and pregnant women.
Precautions for Use
Do not administer by rapid IV infusion or direct IV injection.
Storage
- Below 25ºC
- After dilution, use the solution immediately.
- Discard any unused open vial.